Probiotics in the prevention of eczema: A randomised controlled trial

Archives of Disease in Childhood

Volumn 99, Issue 11, 2014, Pages 1014-1019

  Allen, Stephen J ^a   Jordan, Sue ^b   Storey, Melanie ^a   Thornton, Catherine A ^a   Gravenor, Michael B ^a   Garaiova, Iveta ^c   Plummer, Susan F ^c   Wang, Duolao ^d   Morgan, Gareth ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b SWANSEA UNIVERSITY   (United Kingdom)

^c CULTECH LTD   (United Kingdom)

^d LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EGG PROTEIN; FOOD ALLERGEN; MILK PROTEIN; PLACEBO; PROBIOTIC AGENT;

ADOLESCENT; ARTICLE; ATOPIC DERMATITIS; ATOPY; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BIFIDUM; CHILD; CHILDHOOD DISEASE; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; ECZEMA; FEMALE; GESTATIONAL AGE; HEN; HIGH RISK INFANT; HUMAN; INFANT; LACTOBACILLUS PARACASEI; LACTOBACILLUS SALIVARIUS; MILK; ONSET AGE; OUTCOME ASSESSMENT; PERINATAL PERIOD; PREGNANT WOMAN; PRICK TEST; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SENSITIVITY ANALYSIS; SKIN MANIFESTATION; SKIN TEST; ADULT; FOLLOW UP; INCIDENCE; MALE; NEWBORN; PREGNANCY; PRESCHOOL CHILD;

ADULT; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; ECZEMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; PREGNANCY; PROBIOTICS; QUESTIONNAIRES; SKIN TESTS;

EID: 84907933001     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/archdischild-2013-305799     Document Type: Article

References (41)

1. ISAAC. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998;351:1225-32.
2. Asher MI, Montefort S, Björkstén B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006;368:733-43.
3. Odhiambo JA, Williams HC, Clayton TO, et al. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol 2009;124:1251-8.
4. Flohr C. Recent perspectives on the global epidemiology of childhood eczema. Allergol Immunopathol (Madr) 2011;39:174-82.
5. Bieber T. Atopic dermatitis. Ann Dermatol 2010;22:125-37.
6. Arshad SH, Tariq SM, Matthews S, et al. Sensitization to common allergens and its association with allergic disorders at age 4 years: a whole population birth cohort study. Pediatrics 2001;108:E33.
7. Wüthrich B, Schmid-Grendelmeier P. The atopic eczema/dermatitis syndrome. Epidemiology, natural course, and immunology of the IgE-associated ("extrinsic") and the nonallergic ("intrinsic") AEDS. J Investig Allergol Clin Immunol 2003;13:1-5.
8. Illi S, von Mutius E, Lau S, et al. Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet 2006;368:763-70.
9. Strachan DP. Hayfever, hygiene and household size. BMJ 1989;299:1259-60.
10. Okada H, Kuhn C, Feillet H, et al. The 'hygiene hypothesis' for autoimmune and allergic diseases: an update. Clin Exp Immunol 2010;160:1-9.
11. Yoo J, Tcheurekdjian H, Lynch SV, et al. Microbial manipulation of immune function for asthma prevention: inferences from clinical trials. Proc Am Thorac Soc 2007;4:277-82.
12. FAO/WHO. Report on Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. 2001. ftp://ftp.fao.org/es/esn/food/probio-report-en.pdf (accessed Sep 2013).
13. Tang ML, Lahtinen SJ, Boyle RJ. Probiotics and prebiotics: clinical effects in allergic disease. Curr Opin Pediatr 2010;22:626-34.
14. Ozdemir O. Various effects of different probiotic strains in allergic disorders: an update from laboratory and clinical data. Clin Exp Immunol 2010;160:295-304.
15. Allen SJ, Jordan S, Storey M, et al. Dietary supplementation with lactobacilli and bifidobacteria is well tolerated and not associated with adverse events during late pregnancy and early infancy. J Nutr 2010;140:483-8.
16. Jordan S, Watkins A, Storey M, et al. Volunteer bias in recruitment, retention, and blood sample donation in a randomised controlled trial involving mothers and their children at six months and two years: a longitudinal analysis. PLoS ONE 8: e67912.
17. Kalliomäki M, Salminen S, Arvilommi H, et al. Probiotics in the primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001;357:1076-9.
18. Timmerman HM, Koning CJ, Mulder L, et al. Monostrain, multistrain and multispecies probiotics - A comparison of functionality and efficacy. Int J Food Microbiol 2004;96:219-33.
19. Kunz B, Oranje AP, Labrèze L, et al. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1997;195:10-9.
20. Position paper: allergen standardization and skin tests. The European academy of allergology and clinical immunology. Allergy 1993;48:48-82.
21. Leung DY, Bieber T. Atopic dermatitis. Lancet 2003;361:151-60.
22. Kaur B, Anderson HR, Austin J, et al. Prevalence of asthma symptoms, diagnosis, and treatment in 12-14 year old children across Great Britain (international study of asthma and allergies in childhood, ISAAC UK). BMJ 1998;316:118-24.
23. Wadonda-Kabondo N, Sterne JAC, Golding J, et al. A prospective study of the prevalence and incidence of atopic dermatitis in children aged 0-42 months. Br J Dermatol 2003;149:1023-8.
24. Pelucchi C, Chatenoud L, Turati F, et al. Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis. Epidemiology 2012;23:402-14.
25. Wickens K, Black PN, Stanley TV, et al. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2008;122:788-94.
26. Fiocchi A, Burks W, Bahna SL, et al. Clinical use of probiotics in pediatric allergy (CUPPA): a world allergy organization position paper. World Allergy Organ J 2012;5:148-67.
27. Flohr C. Atopic dermatitis diagnostic criteria and outcome measures for clinical trials: still a mess. J Invest Dermatol 2011;131:557-9.
28. Elazab N, Mendy A, Gasana J, et al. Probiotic administration in early life, Atopy, and Asthma: a meta-analysis of clinical trials. Pediatrics 2013;132:e666-76.
29. Kulig M, Bergmann R, Klettke U, et al. Natural course of sensitization to food and inhalant allergens during the first 6 years of life. J Allergy Clin Immunol 1999;103:1173-9.
30. Abrahamsson TR, Jakobsson T, Bottcher MF, et al. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2007;119:1174-80.
31. Rose MA, Stieglitz F, Köksal A, et al. Efficacy of probiotic Lactobacillus GG on allergic sensitization and asthma in infants at risk. Clin Exp Allergy 2010;40:1398-405.
32. Boyle RJ, Ismail IH, Kivivuori S, et al. Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial. Allergy 2011;66:509-16.
33. Soh SE, Aw M, Gerez I, et al. Probiotic supplementation in the first 6 months of life in at risk Asian infants - effects on eczema and atopic sensitization at the age of 1 year. Clin Exp Allergy 2009;39:571-8.
34. Kopp MV, Hennemuth I, Heinzmann A, et al. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 2008;121:e850-6.
35. Taylor AL, Dunstan JA, Prescott SL. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol 2007;119:184-91.
36. Kalliomaki M, Salminen S, Poussa T, et al. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003;361:1869-71.
37. Kukkonen K, Savilahti E, Haahtela T, et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2007;119:192-8.
38. Niers L, Martin R, Rijkers G, et al. The effects of selected probiotic strains on the development of eczema (the PandA study). Allergy 2009;64:1349-58.
39. West CE, Hammarström ML, Hernell O. Probiotics during weaning reduce the incidence of eczema. Pediatr Allergy Immunol 2009;20:430-7.
40. Kalliomäki M, Antoine JM, Herz U, et al. Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of allergic diseases by probiotics. J Nutr 2010;140:713S-21S.
41. Ker J, Hartert TV. The atopic march: what's the evidence? Ann Allergy Asthma Immunol 2009;103:282-9.